603087 甘李药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.6223.346-4.45015.20717.080
总资产报酬率 ROA (%)4.2383.047-4.09614.27015.845
投入资产回报率 ROIC (%)4.5873.318-4.40615.03913.624

边际利润分析
销售毛利率 (%)75.35773.25976.30089.03490.879
营业利润率 (%)25.04512.089-33.22347.03543.217
息税前利润/营业总收入 (%)22.5018.720-39.52542.05742.979
净利润/营业总收入 (%)22.59513.046-25.66940.22036.608

收益指标分析
经营活动净收益/利润总额(%)57.35198.43788.69193.76697.753
价值变动净收益/利润总额(%)39.70114.835-1.1875.0491.416
营业外收支净额/利润总额(%)0.239-2.9872.335-0.171-0.514

偿债能力分析
流动比率 (X)8.0437.9856.96714.15014.541
速动比率 (X)6.7696.8726.16912.80913.337
资产负债率 (%)8.3038.3019.6286.3215.986
带息债务/全部投入资本 (%)-1.031-1.134-1.156-0.949--
股东权益/带息债务 (%)-9,618.948-8,756.858-8,562.875-10,432.315-18,529.749
股东权益/负债合计 (%)1,104.3901,104.609938.6131,482.0691,570.667
利息保障倍数 (X)-8.641-2.8897.177-8.588-2,516.401

营运能力分析
应收账款周转天数 (天)38.76738.649116.69487.7510.000
存货周转天数 (天)460.878389.502576.622520.2230.000